G267-1085 Screening compound: 3-{3,5-dimethyl-1-[6-(morpholin-4-yl)pyridazin-3-yl]-1H-pyrazol-4-yl}-N-[(4-ethoxyphenyl)methyl]propanamide

G267-1085 Screening compound: 3-{3,5-dimethyl-1-[6-(morpholin-4-yl)pyridazin-3-yl]-1H-pyrazol-4-yl}-N-[(4-ethoxyphenyl)methyl]propanamide
G267-1085 Screening compound: 3-{3,5-dimethyl-1-[6-(morpholin-4-yl)pyridazin-3-yl]-1H-pyrazol-4-yl}-N-[(4-ethoxyphenyl)methyl]propanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound G267-1085
3-{3,5-dimethyl-1-[6-(morpholin-4-yl)pyridazin-3-yl]-1H-pyrazol-4-yl}-N-[(4-ethoxyphenyl)methyl]propanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G267-1085

Molecular Formula

C25H32N6O3 (C25 H32 N6 O3)

Compound Name

3-{3,5-dimethyl-1-[6-(morpholin-4-yl)pyridazin-3-yl]-1H-pyrazol-4-yl}-N-[(4-ethoxyphenyl)methyl]propanamide

IUPAC name

3-{35-dimethyl-1-[6-(morpholin-4-yl)pyridazin-3-yl]-1H-pyrazol-4-yl}-N-[(4-ethoxyphenyl)methyl]propanamide

SMILES

CCOc1ccc(CNC(CCc2c(C)n(-c(cc3)nnc3N3CCOCC3)nc2C)=O)cc1

InChI

InChI=1S/C25H32N6O3/c1-4-34-21-7-5-20(6-8-21)17-26-25(32)12-9-22-18(2)29-31(19(22)3)24-11-10-23(27-28-24)30-13-15-33-16-14-30/h5-8,10-11H,4,9,12-17H2,1-3H3,(H,26,32)

InChI Key

IGBUQEXPWRAZDL-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14992447

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

464.57

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

2.538

Distribution Coefficient, logD

2.467

Water Solubility, LogSw

-2.59

Polar Surface Area

78.011

Acid Dissociation Constant (pKa)

13.88

Base Dissociation Constant (pKb)

6.65

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

44.00

G267-1085 in Drug Discovery

Included in Screening Libraries

3D-Biodiversity Library (27607 compounds)

Antiviral Annotated Library (21441 compounds)

Antiviral Library (67538 compounds)

Selective Target Activity Profiling Library (14702 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Target Identification, Phenotypic Screening library (TIPS) (27612 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system

References: we are preparing a list of scientific research reports with G267-1085 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G267-1085?
Check Price and Availability of G267-1085, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G267-1085 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G267-1085
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G267-1085
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G267-1085 available by request